Steven is Venture Fund Lead at UCB Ventures, the corporate venture arm of UCB Biopharma.
With over 12 years of research experience, Steven gets excited about new scientific discoveries and technological developments, particularly those that improve the life of patients.
Steven obtained a PhD in Neuroimmunology through Janssen R&D’s external innovation program, where he developed novel test systems for depression drug discovery.
Following this, Steven moved to San Diego where he transitioned into human stem cell technology.
Notably, as part of a multidisciplinary R&D team at StemoniX, he developed next generation drug screening assays, managed fee-for-service activities and learned the inner workings of an early-stage biotech company.
At UCB Biopharma, as Senior Scientist, Steven established and managed innovative stem cell technology platforms. In addition to supporting UCB’s preclinical drug discovery projects, he managed internal and outsourced research activities including coordination of licensing, regulatory compliance, technology transfer and service agreements.
Steven is attending / has attended:
Venture Summit Virtual Connect 21